Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

DPP may help hair regrowth by improving blood vessel function under stress.

Taking 5 mg/day finasteride can cause side effects in women with hair loss, but these are usually mild and fade over time, making the treatment beneficial in the long run.

Finasteride helps induce ovulation in nonresponder PCOS women.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Allopregnanolone, a progesterone metabolite, helps reduce restraint effects on behavior.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

The hydrogel with Finasteride provides controlled, sustained drug release and improved bioavailability.

Diane-35 effectively reduces hair loss and thinning in women.

Oral spironolactone effectively promotes hair growth in premenopausal women but may cause irregular menstruation.

Progesterone helps adult male mice's brain cells survive and improves learning and memory.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Allopregnanolone helps control oxytocin levels during pregnancy to prevent preterm labor.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.